The safety of intravenous iron preparations: Systematic review and meta-analysis

Mayo Clinic Proceedings

Volumn 90, Issue 1, 2015, Pages 12-23

  Tomer, Avni ^a   Amir, Bieber ^b   Alon, Grossman ^b   Hefziba, Green ^b   Leonard, Leibovici ^b   Anat, Gafter Gvili ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; PLACEBO;

ABNORMAL LABORATORY RESULT; BONE DISEASE; CARDIOVASCULAR SYMPTOM; CAUSE OF DEATH; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; GASTROINTESTINAL SYMPTOM; HEART FAILURE; HUMAN; HYPERTENSION; HYPOTENSION; INFECTION RISK; INFUSION RELATED REACTION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; MUSCLE DISEASE; NEUROLOGIC DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; REVIEW; SKIN DISEASE; SYSTEMATIC REVIEW; THROMBOEMBOLISM; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URTICARIA; ADVERSE EFFECTS; ANEMIA, IRON-DEFICIENCY; CLASSIFICATION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; OUTCOME ASSESSMENT; PROCEDURES;

ADMINISTRATION, INTRAVENOUS; ANEMIA, IRON-DEFICIENCY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; IRON; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84920439896     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2014.10.007     Document Type: Article

References (133)

1. H. Clarke, and C.J. Pallister The impact of anaemia on outcome in cancer Clinical and laboratory haematology 27 1 2005 1 13
2. H.F. Groenveld, J.L. Januzzi, and K. Damman Anemia and mortality in heart failure patients a systematic review and meta-analysis J Am Coll Caridiol 52 10 2008 818 827
3. M. Auerbach, and H. Ballard Clinical use of intravenous iron: administration, efficacy, and safety Hematol Am Soc Hematol Educ Program 2010 2010 338 347
4. E. Notebaert, J.M. Chauny, M. Albert, S. Fortier, N. Leblanc, and D.R. Williamson Short-term benefits and risks of intravenous iron: a systematic review and meta-analysis Transfusion 47 10 2007 1905 1918
5. T. Avni, L. Leibovici, and A. Gafter-Gvili Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis Eur J Heart Fail 14 4 2012 423 429
6. T. Avni, A. Bieber, T. Steinmetz, L. Leibovici, and A. Gafter-Gvili Treatment of anemia in inflammatory bowel disease- systematic review and meta-analysis PloS One 8 12 2013 e75540
7. B. Rozen-Zvi, A. Gafter-Gvili, M. Paul, L. Leibovici, O. Shpilberg, and U. Gafter Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis Am J Kidney Dis 52 5 2008 897 906
8. J. Albaramki, E.M. Hodson, J.C. Craig, and A.C. Webster Parenteral versus oral iron therapy for adults and children with chronic kidney disease Cochrane Database Syst Rev 1 2012 CD007857
9. P. Susantitaphong, F. Alqahtani, and B.L. Jaber Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis Am J Nephrol 39 2 2014 130 141
10. A. Gafter-Gvili, B. Rozen-Zvi, and L. Vidal Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia: systematic review and meta-analysis of randomised controlled trials Acta Oncol 52 1 2013 18 29
11. L. Reveiz, G.M. Gyte, L.G. Cuervo, and A. Casasbuenas Treatments for iron-deficiency anaemia in pregnancy Cochrane Database Syst Rev 10 2011 CD003094
12. E. Litton, J. Xiao, and K.M. Ho Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials BMJ 347 2013 f4822
13. D.B. Van Wyck, G. Cavallo, and B.S. Spinowitz Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial Am J Kidney Dis 36 1 2000 88 97
14. B.A. Walters, and D.B. Van Wyck Benchmarking iron dextran sensitivity: reactions requiring resuscitative medication in incident and prevalent patients Nephrol Dial Tranplant 20 7 2005 1438 1442
15. R.A. Zager, A.C. Johnson, S.Y. Hanson, and H. Wasse Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury Am J Kidney Dis 40 1 2002 90 103
16. S.D. Anker, J. Comin Colet, and G. Filippatos Ferric carboxymaltose in patients with heart failure and iron deficiency N Engl J Med 361 25 2009 2436 2448
17. S. Fishbane Review of issues relating to iron and infection Am J Kidney Dis 34 4, suppl 2 1999 S47 S52
18. L.T. Goodnough Iron deficiency syndromes and iron-restricted erythropoiesis (CME) Transfusion 52 7 2012 1584 1592
19. Higgins J, Churchill R, Cumpston M, Chandler J, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. Oxford, England: Cochrane Collaboration; 2011.
20. K.F. Schulz, I. Chalmers, R.J. Hayes, and D.G. Altman Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials JAMA 273 5 1995 408 412
21. J.P. Ioannidis, S.J. Evans, and P.C. Gotzsche Better reporting of harms in randomized trials: an extension of the CONSORT statement Ann Intern Med 141 10 2004 781 788
22. US Department of Health and Human Services National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 2012 US Dept of Health and Human Services Washington, DC
23. J.O. Friedrich, N.K. Adhikari, and J. Beyene Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data BMC Med Res Methodol 7 2007 5
24. L. Adhikary, and S. Acharya Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy JNMA J Nepal Med Assoc 51 183 2011 133 136
25. R. Agarwal, A.R. Rizkala, B. Bastani, M.O. Kaskas, D.J. Leehey, and A. Besarab A randomized controlled trial of oral versus intravenous iron in chronic kidney disease Am J Nephrol 26 5 2006 445 454
26. H.K. Aggarwal, N. Nand, S. Singh, M. Singh, Hemant, and G. Kaushik Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin J Associ Physicians India 51 2003 170 174
27. R.A. Al, E. Unlubilgin, O. Kandemir, S. Yalvac, L. Cakir, and A. Haberal Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial Obstet Gynecol 106 6 2005 1335 1340
28. V. Allegra, G. Mengozzi, and A. Vasile Iron deficiency in maintenance hemodialysis patients: assessment of diagnosis criteria and of three different iron treatments Nephron 57 2 1991 175 182
29. R.P. Allen, C.H. Adler, W. Du, A. Butcher, D.B. Bregman, and C.J. Earley Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial Sleep Med 12 9 2011 906 913
30. A. Al-Momen, A. Al-Meshari, and L. Al-Nuaim Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy Eur J Obstet Gynecol Reprod Biol 69 2 1996 121 124
31. G. Arutyunov, N. Bylova, A. Ivleva, and Z. Kobalava The safety of intravenous (IV) ferric carboxymaltose versus IV iron sucrose on patients with chronic heart failure (CHF) and chronic kidney disease (CKD) with iron deficincy (ID) Eur J Heart Fail 8 suppl 2009, 2 2009 ii71
32. P. Athibovonsuk, T. Manchana, and N. Sirisabya Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy Gynecol Oncol 131 3 2013 679 682
33. M. Auerbach, H. Ballard, and J.R. Trout Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial J Clin Oncol 22 7 2004 1301 1307
34. M. Auerbach, P.T. Silberstein, and R.T. Webb Darbepoetin alfa 300 or 500 mug once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia Am J Hematol 85 9 2010 655 663
35. P. Bager, and J.F. Dahlerup Randomised clinical trial: oral vs. intravenous iron after upper gastrointestinal haemorrhage: a placebo-controlled study Aliment Pharmacol Ther 39 2 2014 176 187
36. G.R. Bailie, N.A. Mason, and T.G. Valaoras Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia Hemodial Int 14 1 2010 47 54
37. L. Bastit, A. Vandebroek, and S. Altintas Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia J Clin Oncol 26 10 2008 1611 1618
38. F. Bayoumeu, C. Subiran-Buisset, N.E. Baka, H. Legagneur, P. Monnier-Barbarino, and M.C. Laxenaire Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route Am J Obstet Gynecol 186 3 2002 518 522
39. L. Beck-da-Silva, D. Piardi, and S. Soder IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia Int J Cardiol 168 4 2013 3439 3442
40. Y. Beguin, J. Maertens, and B. De Prijck Darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial Am J Hematol 88 12 2013 990 996
41. R. Bellet, H. Ghazal, and M. Flam A phase III randomized controlled study comparing iron sucrose intravenously (IV) to no iron treatment of anemia in cancer patients undergoing chemotherapy and erythropoietin stimulating agent (ESA) therapy J Clin Oncol 25 18 suppl 2007 9109
42. G. Bencaiova, U. von Mandach, and R. Zimmermann Iron prophylaxis in pregnancy: intravenous route versus oral route Eur J Obstet Gynecol Reprod Biol 144 2 2009 135 139
43. N. Bhandal, and R. Russell Intravenous versus oral iron therapy for postpartum anaemia BJOG 113 11 2006 1248 1252
44. G. Birgegard, K. Schneider, and J. Ulfberg High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron Vox Sang 99 4 2010 354 361
45. C. Breymann, F. Gliga, C. Bejenariu, and N. Strizhova Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia Int J Gynaecol Obstet 101 1 2008 67 73
46. D.L. Burns, E.A. Mascioli, and B.R. Bistrian Effect of iron-supplemented total parenteral nutrition in patients with iron deficiency anemia Nutrition 12 6 1996 411 415
47. C. Charytan, M.V. Bernardo, T.A. Koch, A. Butcher, D. Morris, and D.B. Bregman Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study Nephrol Dial Transplant 28 4 2013 953 964
48. C. Charytan, W. Qunibi, G.R. Bailie Venofer Clinical Studies Group Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis Nephron Clin Pract 100 3 2005 c55 c62
49. D.W. Coyne, T. Kapoian, and W. Suki Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study J Am Soc Nephrol 18 3 2007 975 984
50. P. Dangsuwan, and T. Manchana Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy Gynecol Oncol 116 3 2010 522 525
51. A. Daniilidis, C. Giannoulis, A. Pantelis, T. Tantanasis, and K. Dinas Total infusion of low molecular weight iron-dextran for treating postpartum anemia Clin Exp Obstet Gynecol 38 2 2011 159 161
52. D.W. Dawson, W.O. Goldthorp, and D. Spencer Parenteral iron therapy in pregnancy J Obstet Gynaecol of the Br Commonw 72 1965 89 93
53. J.V. Dhanani, B.P. Ganguly, and L.N. Chauhan Comparison of efficacy and safety of two parenteral iron preparations in pregnant women J Pharmacol Pharmcother 3 4 2012 314 319
54. C.J. Earley, A. Horska, M.A. Mohamed, P.B. Barker, J.L. Beard, and R.P. Allen A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome Sleep Med 10 2 2009 206 211
55. T.J. Edwards, E.J. Noble, A. Durran, N. Mellor, and K.B. Hosie Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery Br J Surg 96 10 2009 1122 1128
56. K. Erichsen, R.J. Ulvik, and G. Nysaeter Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease Scand J Gastroenterol 40 9 2005 1058 1065
57. R. Evstatiev, O. Alexeeva, and B. Bokemeyer Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease Clin Gastroenterol Hepatol 11 3 2013 269 277
58. S. Fishbane, G.L. Frei, and J. Maesaka Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation Am J Kidney Dis 26 1 1995 41 46
59. B. Froessler, C. Cocchiaro, K. Saadat-Gilani, N. Hodyl, and G. Dekker Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial J Matern Fetal Neonatal Med 26 7 2013 654 659
60. P. Garrido-Martin, M.I. Nassar-Mansur, and R. de la Llana-Ducros The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial Interact Cardiovasc Thorac Surg 15 6 2012 1013 1018
61. C. Giannoulis, A. Daniilidis, T. Tantanasis, K. Dinas, and J. Tzafettas Intravenous administration of iron sucrose for treating anemia in postpartum women Hippokratia 13 1 2009 38 40
62. L. Grote, L. Leissner, J. Hedner, and J. Ulfberg A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome Mov Disord 24 10 2009 1445 1452
63. M. Hedenus, G. Birgegard, and P. Nasman Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study Leukemia 21 4 2007 627 632
64. D.H. Henry, N.V. Dahl, M. Auerbach, S. Tchekmedyian, and L.R. Laufman Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy Oncologist 12 2 2007 231 242
65. R. Hussain, S. Christi, and S. Naqvi Experience of iron saccharate supplementation in haemodialysis patients treated with erythropoietin Nephrology 4 1-2 1998 105 108
66. Kalra P, Thomsen L. Effect of iron isomaltoside 1000 on phosphate levels in patients with non-dialysis dependent chronic kidney disease. American Society of Nephrology, kidney week 2012 abstract supplement, page 687A. https://www.asn-online.org/education/kidneyweek/archives/. Accessed February 19, 2013.
67. K. Karkouti, S.A. McCluskey, M. Ghannam, M.J. Salpeter, I. Quirt, and T.M. Yau Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia Can J Anaesth 53 1 2006 11 19
68. A. Khalafallah, A. Dennis, and J. Bates A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy J Intern Med 268 3 2010 286 295
69. Y.H. Kim, H.H. Chung, S.B. Kang, S.C. Kim, and Y.T. Kim Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study Acta Haematol 121 1 2009 37 41
70. Y.T. Kim, S.W. Kim, and B.S. Yoon Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy Gynecol Oncol 105 1 2007 199 204
71. P.K. Kochhar, A. Kaundal, and P. Ghosh Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial J Obstet Gynaecol Res 39 2 2013 504 510
72. M. Kotaki, K. Uday, M. Henriquez, S. Blum, and M. Dave Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin Clin Nephrol 48 1 1997 63 64
73. P.A. Krayenbuehl, E. Battegay, C. Breymann, J. Furrer, and G. Schulthess Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration Blood 118 12 2011 3222 3227
74. S. Kulnigg, S. Stoinov, and V. Simanenkov A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial Am J Gastroenterol 103 5 2008 1182 1192
75. S. Kulnigg-Dabsch, W. Schmid, and S. Howaldt Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial Inflamm Bowel Dis 19 8 2013 1609 1616
76. K.L. Kuo, S.C. Hung, Y.H. Wei, and D.C. Tarng Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients J Am Soc Nephrol 19 9 2008 1817 1826
77. H. Li, and S.X. Wang Intravenous iron sucrose in peritoneal dialysis patients with renal anemia Perit Dial Int 28 2 2008 149 154
78. H. Li, and S.X. Wang Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia Blood Purif 26 2 2008 151 156
79. H. Li, and S.X. Wang Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study [in Chinese] Zhonghua Yi Xue Za Zhi 89 7 2009 457 462
80. S. Lindgren, O. Wikman, and R. Befrits Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study Scand J Gastroenterol 44 7 2009 838 845
81. I.C. Macdougall, B. Tucker, J. Thompson, C.R. Tomson, L.R. Baker, and A.E. Raine A randomized controlled study of iron supplementation in patients treated with erythropoietin Kidney Int 50 5 1996 1694 1699
82. S.N. Madi-Jebara, G.S. Sleilaty, and P.E. Achouh Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery J Cardiothorac Vasc Anesth 18 1 2004 59 63
83. L.P. McMahon, A.B. Kent, and P.G. Kerr Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial Nephrol Dial Transplant 25 3 2010 920 926
84. B. Michael, D.W. Coyne, and S. Fishbane Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran Kidney Int 61 5 2002 1830 1839
85. D.W. Mudge, K.S. Tan, and R. Miles A randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation Transplantation 93 8 2012 822 826
86. S.P. Nagaraju, A. Cohn, A. Akbari, J.L. Davis, and D.L. Zimmerman Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial BMC Nephrol 14 2013 64
87. S. Neeru, N.S. Nair, and L. Rai Iron sucrose versus oral iron therapy in pregnancy anemia Ind J Community Med 37 4 2012 214 218
88. D.O. Okonko, A. Grzeslo, and T. Witkowski Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial J Am Coll Cardiol 51 2 2008 103 112
89. G. Olijhoek, J.G. Megens, and P. Musto Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trial Transfusion 41 7 2001 957 963
90. O.A. Oluboyede, O. Ogunbode, and O. Ayeni Iron deficiency anaemia during pregnancy a comparative trial of treatment by iron-poly (sorbitol-gluconic acid) complex Ferastral given intramuscularly and iron dextran (Imferon) by total dose infusion East Afr Med J 57 9 1980 626 633
91. J.E. Onken, D.B. Bregman, and R.A. Harrington A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia Transfusion 54 2 2014 306 315
92. P. Pedrazzoli, A. Farris, and S. Del Prete Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha J Clin Oncol 26 10 2008 1619 1625
93. R. Provenzano, B. Schiller, M. Rao, D. Coyne, L. Brenner, and B.J. Pereira Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients Clin J Am Soc Nephrol 4 2 2009 386 393
94. W.Y. Qunibi, C. Martinez, M. Smith, J. Benjamin, A. Mangione, and S.D. Roger A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients Nephrol Dial Transplant 26 5 2011 1599 1607
95. W. Reinisch, M. Staun, and R.K. Tandon A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED) Am J Gastroenterol 108 12 2013 1877 1888
96. R.G. Rohling, A.P. Zimmermann, and C. Breymann Intravenous versus oral iron supplementation for preoperative stimulation of hemoglobin synthesis using recombinant human erythropoietin J Hemother Stem Cell Res 9 4 2000 497 500
97. G. Schaller, B. Scheiber-Mojdehkar, and M. Wolzt Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients Kidney Int 68 6 2005 2814 2822
98. E. Schindler, S. Scholz, and J. Boldt Effectiveness of oral versus parenteral iron substitution in autologous blood donors [in German] Infusionsther Transfusionsmed 21 4 1994 236 241
99. O. Schroder, O. Mickisch, and U. Seidler Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease: a randomized, controlled, open-label, multicenter study Am J Gastroenterol 100 11 2005 2503 2509
100. M.H. Seid, R.J. Derman, J.B. Baker, W. Banach, C. Goldberg, and R. Rogers Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial Am J Obstet Gynecol 199 4 2008 435.e1 435.e7
101. J.A. Serrano-Trenas, P.F. Ugalde, L.M. Cabello, L.C. Chofles, P.S. Lazaro, and P.C. Benitez Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial Transfusion 51 1 2011 97 104
102. D. Shafi, S.V. Purandare, and A.V. Sathe Iron deficiency anemia in pregnancy: intravenous versus oral route J Obstet Gynaecol India 62 3 2012 317 321
103. A. Singh, T. Patel, J. Hertel, M. Bernardo, A. Kausz, and L. Brenner Safety of ferumoxytol in patients with anemia and CKD Am J Kidney Dis 52 5 2008 907 915
104. H. Singh, J. Reed, S. Noble, J.L. Cangiano, D.B. Van Wyck United States Iron Sucrose Clinical Trials Group Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial Clin J Am Soc Nephrol 1 3 2006 475 482
105. K. Singh, Y.F. Fong, and P. Kuperan A comparison between intravenous iron polymaltose complex (Ferrum Hausmann) and oral ferrous fumarate in the treatment of iron deficiency anaemia in pregnancy Eur J Haemotol 60 2 1998 119 124
106. J.A. Sloand, M.A. Shelly, A. Feigin, P. Bernstein, and R.D. Monk A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome Am J Kidney Dis 43 4 2004 663 670
107. S.K. Sood, K. Ramachandran, and K. Rani WHO sponsored collaborative studies on nutritional anaemia in India. The effect of parenteral iron administration in the control of anaemia of pregnancy Br J Nutr 42 3 1979 399 406
108. B.S. Spinowitz, A.T. Kausz, and J. Baptista Ferumoxytol for treating iron deficiency anemia in CKD J Am Soc Nephrol 19 8 2008 1599 1605
109. D.P. Steensma, J.A. Sloan, and S.R. Dakhil Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia J Clin Oncol 29 1 2011 97 105
110. M.L. Stein, K.D. Gunston, and R.M. May Iron dextran in the treatment of iron-deficiency anaemia of pregnancy: haematological response and incidence of side-effects S Afr Med J 79 4 1991 195 196
111. J. Stoves, H. Inglis, and C.G. Newstead A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin Nephrol Dial Transplant 16 5 2001 967 974
112. I.D. Strickland, D.M. Chaput de Saintonge, F.E. Boulton, B. Francis, J. Roubikova, and J.I. Waters The therapeutic equivalence of oral and intravenous iron in renal dialysis patients Clin Nephrol 7 2 1977 55 57
113. F. Svara, S. Sulkova, J. Kvasnicka, and V. Polakovic Iron supplementation during erythropoietin therapy in patients on hemodialysis [article in Czech] Vnitr Lek 42 12 1996 849 852
114. N.P. Talbot, T.G. Smith, and C. Privat Intravenous iron supplementation may protect against acute mountain sickness: a randomized, double-blinded, placebo-controlled trial High Alt Med Biol 12 3 2011 265 269
115. J.E. Toblli, A. Lombrana, P. Duarte, and F. Di Gennaro Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency J Am Coll Cardiol 50 17 2007 1657 1665
116. S. Vadhan-Raj, W. Strauss, and D. Ford Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron Am J Hematol 89 1 2014 7 12
117. C.E. van Iperen, C.A. Gaillard, R.J. Kraaijenhagen, B.G. Braam, J.J. Marx, and A. van de Wiel Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients Crit Care Med 28 8 2000 2773 2778
118. D.B. Van Wyck, A. Mangione, J. Morrison, P.E. Hadley, J.A. Jehle, and L.T. Goodnough Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial Transfusion 49 12 2009 2719 2728
119. D.B. Van Wyck, M.G. Martens, M.H. Seid, J.B. Baker, and A. Mangione Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial Obstet Gynecol 110 2, pt 1 2007 267 278
120. D.B. Van Wyck, M. Roppolo, C.O. Martinez, R.M. Mazey, S. McMurray United States Iron Sucrose Clinical Trials Group A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD Kidney Int 68 6 2005 2846 2856
121. S. Verma, S. Inamdar, and N. Malhotra Intravenous iron therapy versus oral iron in postpartum patients in rural area J S Asian Fed Obstet Gynaecol 3 2 2011 67 70
122. A. Wali, A. Mushtaq, and Nilofer Comparative study: efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy J Pakistan Med Assoc 52 9 2002 392 395
123. V. Weisbach, P. Skoda, and R. Rippel Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: a randomized, controlled study Transfusion 39 5 1999 465 472
124. S. Westad, B. Backe, and K.A. Salvesen A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia Acta Obstet Gynecol Scand 87 9 2008 916 923
125. L. Yin, X. Chen, J. Chen, M. Cheng, Y. Peng, and L. Yang Multi-frequency low-dose intravenous iron on oxidative stress in maintenance hemodialysis patients [article in Chinese] Zhong Nan Da Xue Xue Bao Yi Xue Ban 37 8 2012 844 848
126. R.A. Moore, H. Gaskell, P. Rose, and J. Allan Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data BMC Blood Disord 11 2011 4
127. B. Hoen, A. Paul-Dauphin, D. Hestin, and M. Kessler EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients J AM Soc Nephrol 9 5 1998 869 876
128. B. Hoen, A. Paul-Dauphin, and M. Kessler Intravenous iron administration does not significantly increase the risk of bacteremia in chronic hemodialysis patients Clin Nephrol 57 6 2002 457 461
129. J.M. Rohde, D.E. Dimcheff, and N. Blumberg Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis JAMA 311 13 2014 1317 1326
130. M. Auerbach, H. Ballard, and J. Glaspy Clinical update: intravenous iron for anaemia Lancet 369 9572 2007 1502 1504
131. D. Baribeault, and M. Auerbach Iron replacement therapy in cancer-related anemia Am J Health Syst Pharm 68 10, suppl 1 2011 S4 S16
132. P.H. Bolton-Maggs, and H. Cohen Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety Br J Haematol 163 3 2013 303 314
133. G.M. Chertow, P.D. Mason, O. Vaage-Nilsen, and J. Ahlmen Update on adverse drug events associated with parenteral iron Nephrol Dial Transplant 21 2 2006 378 382